blue4uQianmengYu:
Previously, HBV clinical data were good. They were all 60-70, so antibodies weren't on the market yet. However, COVID-19 antibodies can still fall if they are effective, and the market is clearly underestimated
QianmengYublue4u:
This is so ridiculous . It's time to catch up with agencies frantically shorting small herbal medicines. I made a mistake along the way. So I can only continue to carry it hard
102355763 : Bullish only if the new variant is even more contagious than Omicron n more deadly than any of the earlier strains
QianmengYu : vir is too cheap now, shrunk. Unfortunately, I've already bought it all (this requires controlling positions).
blue4u QianmengYu: Previously, HBV clinical data were good. They were all 60-70, so antibodies weren't on the market yet. However, COVID-19 antibodies can still fall if they are effective, and the market is clearly underestimated
QianmengYu blue4u: This is so ridiculous
. It's time to catch up with agencies frantically shorting small herbal medicines. I made a mistake along the way. So I can only continue to carry it hard
blue4u QianmengYu: US stocks generally fell today, the epidemic was serious, only vaccine stocks rose